Gert Jan Lammers, PhD, MD

Quality of Life, Functional Evaluation, and Work Productivity in Patients With Narcolepsy: Results From a Phase 3 Study of Solriamfetol (JZP-110)

INTRODUCTION: Solriamfetol, a selective dopamine/norepinephrine reuptake inhibitor, significantly decreased excessive sleepiness in a randomized, double-blind, placebo-controlled study of...

Michael Thorpy , MD, CHBC;

Giuseppe Plazzi , MD;

Yves Dauvilliers , MD, PhD;

Colin Shapiro , PhD, FRCPC, MBBCh;

Jed Black , MD;

Geert Mayer , MD;

Helene Emsellem , MD;

Dandan Chen , MD, PhD;

Robert Ryan , MS;

Gert Jan Lammers , PhD, MD;

Chevy Chase , MD;

Lawrence Carter , PhD;

03/01/2019

Effects of Solriamfetol on Driving Performance in Participants With Narcolepsy

Introduction: Solriamfetol, a dopamine/norepinephrine reuptake inhibitor, is approved in the US and EU to improve wakefulness in adults with excessive daytime sleepiness (EDS) associated ...

Dandan Chen , MD, PhD;

Frederick Vinckenbosch , MSc;

Gert Jan Lammers , PhD, MD;

Sebastiaan Overeem , MD, PhD;

Grace Wang , MD, MS;

Lawrence Carter , PhD;

Kefei Zhou , PhD;

Johannes Ramaekers , PhD;

Annemiek Vermeeren , PhD;

10/08/2020

Effects of Solriamfetol on Driving Performance in Participants With Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea

Introduction: Solriamfetol, a dopamine/norepinephrine reuptake inhibitor, is approved (US and EU) to treat excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA;...

Johannes Ramaekers , PhD;

Annemiek Vermeeren , PhD;

Jerryll Asin , MD;

Nicolaas de Vries , MD, PhD;

Patty Vonk , MD;

Claire Donjacour , MD, PhD;

Hennie Janssen , MD, PhD;

Dandan Chen , MD, PhD;

Frederick Vinckenbosch , MSc;

Gert Jan Lammers , PhD, MD;

Sebastiaan Overeem , MD, PhD;

Grace Wang , MD, MS;